UCMR is a national Linnaeus Center of Excellence at Umeå University that promotes interdisciplinary cutting-edge microbial and translational research. The latest groundbreaking discovery is Emmanuelle Charpentier's work on the CRISPR-Cas9 mechanism, for which she was awarded the 2020 Nobel Prize in Chemistry.
"The jewel in the crown"
UCMR is located at Umeå University, the flagship university in Northern Sweden. It is an interdisciplinary consortium of academic research groups with outstanding track records in the fields of microbial pathogenesis, molecular and cell biology, chemistry, clinical microbiology, structural biology, immunology, epidemiology, microbial ecology, physics, mathematics, and data-driven science.
Together, with joined forces UCMR is establish a world-leading and sustainable science environment promoting cutting-edge biomedical research in molecular infection medicine at Umeå University. As of today, nearly 70 Principal Investigators and their research groups are affiliated to UCMR.
The recent ground-breaking discovery is Emmanuelle Charpentier’s seminal work of the CRISPR-Cas9 mechanism, for which she was awarded Nobel Prize in Chemistry in 2020. When the discovery was made, Emmanuelle Charpentier was active at Umeå University. She was one of the first recruited group leaders at the Laboratory for Molecular Infection Medicine Sweden (MIMS) within UCMR.
UCMR is a Linnaeus Center of Excellence in Sweden. In 2008 the consortium was awarded a 10-year grant from the Swedish Research Council. In 2020 the 40 different Centers of Excellence within the Linnaeus programme were evaluated by an international expert panel. UCMR was ranked among the top three in all three areas; research performance, societal relevance and international competitiveness. The expert panel characterized UCMR as "the jewel in the crown".
The vision and mission
The vision of UCMR is to develop a world-leading science environment promoting cutting-edge molecular and translational research in microbial infection.
Missions of UCMR:
To conduct and develop high-quality research and education in molecular and translational infection research
To strengthen and develop a multidisciplinary research platform and promote new synergies and collaborations
To train the next-generation scientists and clinicians
To overcome societal challenges posed by microbial infectious diseases